Exceptional Responders Pilot Study: Molecular Profiling Of Tumors From Cancer Patients Who Are Exceptional Responders
Posted Date: May 15, 2019
- Investigator: John Morris
- Type of Study: Drug
This study is a first step in investigating what changes in genes might make cancer patients responded well to certain drugs. We would like to test your previously collected cancer tissue, and if available your normal tissue, to find out if your response could have been caused by a change in your ge
Criteria:
To Be Eligible For This Study, Patients Must Have Been Diagnosed With A Type Of Cancer, Have Tumor S
Keywords:
Exceptional Responde, Nci9671, Oncology, Cancer, Solid Tumor
For More Information:
Uc Cancer Center
513-584-7698
kastla@uc.edu